
The famous short selling hedge fund, Kerrisdale Capital, is out with its Q3 letter.
Today, the China Medical Technologies, Inc. (PINK:CMEDQ) saga is over, and we can do an appropriate post-mortem. We established our initial short position in China Medical in the fourth quarter of 2012, when Glaucus Research published a report alleging that China Medical Technologies, Inc. (PINK:CMEDQ) management was committing fraud. We generated some returns from the position and at the end of the year assumed that China Medical would just become one of the many Chinese fraudcaps that populated our general short basket at the time.
Every month and quarter, multiple reports on average hedge fund returns are released from several sources. However, it can be difficult to sift through the many returns to uncover the most consistent hedge funds. The good news is that Eric Uhlfelder recently released his "2022 Survey of the Top 50 Hedge Funds," which ranks the Read More
Kerrisdale Capital Q3
Updated on